Subject Notification of the Board of Directors No.6/2018 Re: Convening the Extraordinary Shareholders’ Meeting No.1/2018; an Acquisition of Assets and Connected Transaction for the Entire Business Transfer
) Consolidated The Company only ( 20..) ( 20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse repurchase agreement 4. Investments
20.. Assets (Unit:Baht) Consolidated The Company only (20..) (20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse
) ………………………………….20.. and 20.. Assets (Unit:Baht) Consolidated The Company only (20..) (20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under
1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and
. 1/2018. 2. Approved the appropriation and retaining of the net profit Baht 511 million as legal reserve and the declaration of dividend payment from the Company consolidated net profit for the period
money received from the IPO after deducting the actual expenses 4. Acquisition of all ordinary shares of Modern Pharma Company Limited, "Modern Company", which is a transaction concerning asset
“Company”) submitted its separate financial statement and its consolidated financial statement for the first quarter of 2019 ended on 31 March 2019 which were reviewed by the auditor. The Company hereby
support the growth of the Company group in the future including Fintech in Thailand. In the first quarter of 2019, the Company had operating results according to the consolidated financial statements, with